This important finding, together with our previous observation that frataxin deficiency leads to reduced levels of PGC-1α and its target genes in most investigated cell types prompted us to study whether PGC-1α could be involved in the blunted antioxidant response in FRDA. The gene discussed is PPARGC1A; the disease is Friedreich ataxia.